Middle East & Africa Tissue Engineering Market Forecast to 2028 – COVID

Middle East & Africa Tissue Engineering Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Material Type (Synthetic Material, Biologically Derived Materials, and Others) and Application (Orthopedic, Musculoskeletal & Spine, Neurology, Cardiology & Vascular, Skin & Integumentary, Urology, GI & Gynecology, Cancer, and Others)

Report Code : BMIRE00025952 | Region : LAMEA | Industry : Biotechnology | Published Date : 15/Sep/2022

The tissue engineering market in Middle East & Africa is expected to grow from US$493.55 million in 2022 to US$ 954.80 million by 2028. It is estimated to grow at a CAGR of 9.9% from 2022 to 2028.

The rising chronic illness cases, increasing geriatric population, and surging pediatric care need are a few of the primary factors boosting the growth of the healthcare sector. The sector has been experiencing rapid transformation since the last couple of years. Various countries across the region use advanced technologies in healthcare. With an increase in the need for better healthcare facilities, technology-enabled care (TEC) solutions are in demand in the healthcare systems, especially in the emerging economies. As a result, various healthcare players are investing significant amounts of their revenues in R&D activities to develop advanced solutions, including stem cell products, and associated therapeutic technologies. Also, reimbursements provided for various medical procedures are likely to fuel the growth of this sector during the forecast period. The abovementioned factors are expected to generate growth opportunities for the tissue engineering market players during 2021–2028.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa tissue engineering market at a substantial CAGR during the forecast period.

Middle East & Africa Tissue Engineering Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Tissue Engineering Market Segmentation

The Middle East & Africa tissue engineering market is segmented on the basis of material type, application, and country. Based on material type, the market is segmented into biologically derived materials, synthetic materials, and others. In 2022, the biologically derived materials segment held the largest market share. However, the synthetic materials segment is expected to register the highest CAGR during the forecast period. Based on application, the market is segmented into orthopedic, musculoskeletal & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi & gynecology, urology, and others. In 2022, the orthopedic, musculoskeletal, & spine segment held the largest market share. However, the skin & integumentary segment is expected to register the highest CAGR in the market during the forecast period. Based on country, the Middle East & Africa tissue engineering market is segmented into the UAE, Saudi Arabia, South Africa, and Rest of MEA. In 2022, the UAE held the largest market share; and it is also expected to grow at the fastest CAGR during the forecast period.

Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. are among the leading companies in the Middle East & Africa tissue engineering market.

At 9.9% CAGR, the Middle East & Africa Tissue Engineering Market is speculated to be worth US$ 954.80 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Middle East & Africa tissue engineering market was valued at US$ 493.55 million in 2022 and is expected to reach US$ 954.80 million by 2028, registering an annual growth rate of 9.9% from 2022 to 2028. Heighten advancements in regenerative medicine and rise in the healthcare market across the region.

Tissue engineering and regenerative medicine have been proposed and developed for more than 30 years. Although several successful attempts at tissue regeneration have been made, tissue engineering and regenerative medicine (TERM) is still in its infancy. Many fundamental questions remain to be answered, including the selection of cell sources, the development of tissue-specific materials, specialized bioreactors, and the construction of complex organs. After all, most therapies or treatments aim to enhance tissue regeneration, and stem cell engineering has opened a new avenue in regenerative medicine. Tissue engineering can be applied to construct various tissues such as blood vessels, nerve tissue, skin, and bones. Several techniques should be developed for stem cell engineering involving new materials, new structures, and novel surface modifications of biomaterials; a deeper understanding of the interactions between cells and biomaterials is needed. Advances in tissue engineering research and its methodology led to the formation of scaffolds for bioprinters and then to the decellularized organs. More research into processes is overcoming the shortcomings of previous methods. Improving knowledge in the biology of regeneration, development in microelectronics, and 3D printing technology helps overcome the hurdles. Rapid advancements in the development of regenerative medicines to provide more effective solutions for chronic conditions are driving the growth of the market. Cell therapy is one of the fastest-growing segments of the regenerative medicines domain. Novartis’s Kymriah was the first cell therapy solution offered for the treatment of B-cell acute leukemia, which opened opportunities for this emerging treatment therapy. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in pipeline, with three products—RCH-01, RCS-01, and RCT-01—in the development phase. Further, Sernova is engaged in the development of regenerative medicine technologies and has a huge pipeline of the products for conditions such as Diabetes, Hemophilia A, and hyperthyroidism. Therefore, owing to the above-mentioned advancements the market for tissue engineering is expected to grow in the future.

On the contrary, exorbitant cost of treatment options involving tissue engineering.

Based on material type, the Middle East & Africa tissue engineering market is segment into biologically derived materials, synthetic materials, and others. The biologically derived materials segment held 52.6% market share in 2022, amassing US$ 259.42 million. It is projected to garner US$ 504.69 million by 2028 to expand at 10.0% CAGR during 2022–2028.

Based on application, the Middle East & Africa tissue engineering market is segmented into orthopedic, musculoskeletal, & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi, gynecology, urology, and others. The orthopedic, musculoskeletal, & spine segment held 34.2% market share in 2022, amassing US$ 169.38 million. It is projected to garner US$ 329.29 million by 2028 to expand at 10.0% CAGR during 2022–2028.

Based on country, the Middle East & Africa tissue engineering market has been segmented into the UAE, Saudi Arabia , South Africa, and Rest of MEA. Our regional analysis states that the UAE captured 43.1% market share in 2022. It was assessed at US$ 212.54 million in 2022 and is likely to hit US$ 431.12 million by 2028, exhibiting a CAGR of 10.6% during the forecast period.

Key players dominating the Middle East & Africa tissue engineering market are Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. among others.

In Feb 2017 Allergan acquired LifeCell Corporation, a regenerative medicine company, to strengthen its medical aesthetic, breast implants and tissue expander product portfolio.

In November 2021, Stryker announced that it had completed the previously announced acquisition of Wright Medical Group N.V., a global medical device company focused on extremities and biologics.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Tissue Engineering Market – By Material Type

1.3.2 Middle East & Africa Tissue Engineering Market – By Application

1.3.3 Middle East & Africa Tissue Engineering Market – By Country

2. Middle East & Africa Tissue Engineering Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Tissue Engineering – Market Landscape

4.1 Overview

4.2 Expert Opinion

5. Middle East & Africa Tissue Engineering Market – Industry Dynamics

5.1 Key Drivers

5.1.1 Fostering Number of Road Accidents and Trauma Injuries, and Elevating Incidence of Chronic Diseases

5.1.2 Burgeoning Technological Advancements in the Field of 3D Tissue Engineering

5.2 Key Market Restraints

5.2.1 Exorbitant Cost of Treatment Options Involving Tissue Engineering

5.3 Key Market Opportunities

5.3.1 Rise in the Healthcare Market Across the Region

5.4 Future Trends

5.4.1 Heighten Advancements in Regenerative Medicine

5.5 Impact Analysis

6. Middle East & Africa Tissue Engineering Market Analysis

6.1 Middle East & Africa Tissue Engineering Market Revenue Forecast and Analysis

7. Middle East & Africa Tissue Engineering Market Analysis – By Material Type

7.1 Overview

7.2 Middle East & Africa Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)

7.3 Synthetic Material

7.3.1 Overview

7.3.2 Synthetic Material: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Biologically Derived Materials

7.4.1 Overview

7.4.2 Biologically Derived Materials: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Tissue Engineering Market – By Application

8.1 Overview

8.2 Middle East & Africa Tissue Engineering Market, by Application, 2022 and 2028 (%)

8.3 Orthopedic, Musculoskeletal & Spine

8.3.1 Overview

8.3.2 Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Neurology

8.4.1 Overview

8.4.2 Neurology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Cardiology & Vascular

8.5.1 Overview

8.5.2 Cardiology & Vascular: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Skin & Integumentary

8.6.1 Overview

8.6.2 Skin & Integumentary: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Cancer

8.7.1 Overview

8.7.2 Cancer: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.8 GI & Gynaecology

8.8.1 Overview

8.8.2 GI & Gynaecology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.9 Urology

8.9.1 Overview

8.9.2 Urology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

8.10 Others

8.10.1 Overview

8.10.2 Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Tissue Engineering Market – Country Analysis

9.1 Overview

9.1.1 Middle East & Africa: Tissue Engineering Market Share by Country – 2022 & 2028, (%)

9.1.1.1 Saudi Arabia: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 Saudi Arabia: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.2 Saudi Arabia Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.3 Saudi Arabia Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2 UAE: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 UAE: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.2 UAE Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.3 UAE Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3 South Africa: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 South Africa: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.2 South Africa Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.3 South Africa Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4 Rest of Middle East & Africa: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1 Rest of Middle East & Africa: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.2 Rest of Middle East & Africa Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.3 Rest of Middle East & Africa Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Tissue Engineering Market – Industry Landscape

10.1 Organic Developments

10.1.1 Overview

10.2 Inorganic Developments

10.2.1 Overview

11. Company Profiles

11.1 Zimmer Biomet

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 B. Braun Melsungen AG

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Stryker Corporation

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 AbbVie, Inc.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Integra LifeSciences Holdings Corporation

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Medtronic

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Baxter International Inc.

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Johnson and Johnson Services, Inc.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 3M

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 Cook Biotech Inc.

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1.             Saudi Arabia Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Saudi Arabia Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 3.             UAE Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             UAE Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5.             South Africa Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             South Africa Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Rest of Middle East & Africa Tissue Engineering Market, by Material Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Rest of Middle East & Africa Tissue Engineering Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Organic Developments Done By Companies

Table 10.          Inorganic Developments Done By Companies

Table 11.          Glossary of Terms, Middle East & Africa Tissue Engineering market

LIST OF FIGURES.

Figure 1.           Middle East & Africa Tissue Engineering Market Segmentation

Figure 2.           Middle East & Africa Tissue Engineering Segmentation - By Country

Figure 3.           Middle East & Africa Tissue Engineering Market Overview

Figure 4.           The Biologically Derived Materials Segment Held Largest Share Of Material Type Segment In Tissue Engineering Market

Figure 5.           The UAE Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Middle East & Africa Tissue Engineering Market, Industry Landscape

Figure 7.           Middle East & Africa PEST Analysis

Figure 8.           Middle East & Africa Tissue Engineering Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Middle East & Africa Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)

Figure 10.        Synthetic Material: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Biologically Derived Materials: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Middle East & Africa Tissue Engineering Market, by Application, 2022 and 2028 (%)

Figure 14.        Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Neurology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Cardiology & Vascular: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Skin & Integumentary: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        GI & Gynecology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Urology: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Middle East & Africa: Tissue Engineering Market, by Key Country – Revenue (2022) (US$ Million)

Figure 23.        Middle East & Africa: Tissue Engineering Market Share by Country – 2022 & 2028, (%)

Figure 24.        Saudi Arabia: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        UAE: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        South Africa: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Rest of Middle East & Africa: Tissue Engineering Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - Middle East & Africa Tissue Engineering Market

● Zimmer Biomet

● B. Braun Melsungen AG

● Stryker Corporation

● AbbVie, Inc.

● Integra LifeSciences Holdings Corporation      

● Medtronic

● Baxter International Inc.

● Johnson and Johnson Services, Inc.

● 3M

● Cook Biotech Inc.

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa tissue engineering market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa tissue engineering market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the tissue engineering market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP